Cell Signaling Technology

Product Pathways - Cell Cycle / Checkpoint

Rb Control Proteins #9303

Molecular Weight

76

Description

Nonphosphorylated Rb-C Fusion Protein (5 µg/ml): Rb-C is expressed as a recombinant fusion protein of Rb residues 701?928 and maltose binding protein, serves as a negative control. Supplied in SDS Sample Buffer.Phosphorylated Rb-C Fusion Protein (5 µg/ml): Prepared by in vitro kinase reaction with cdc2, serves as a positive control. Supplied in SDS Sample Buffer.

Directions for Use

As controls, CST recommends using 10 µl (50 ng) of phosphorylated and nonphosphorylated control extracts.

Background

The retinoblastoma tumor suppressor protein, Rb, regulates cell proliferation by controlling progression through the restriction point within the G1-phase of the cell cycle (1). Rb has three functionally distinct binding domains and interacts with critical regulatory proteins including the E2F family of transcription factors, c-Abl tyrosine kinase and proteins with a conserved LXCXE motif (2-4). Cell cycle-dependent phosphorylation by a CDK inhibits Rb target binding and allows cell cycle progression (5). Rb inactivation and subsequent cell cycle progression likely requires an initial phosphorylation by cyclin D-CDK4/6 followed by cyclin E-CDK2 phosphorylation (6). Specificity of different CDK/cyclin complexes has been observed in vitro (6-8) and cyclin D1 is required for Ser780 phosphorylation in vivo (9).

  1. Sherr, C.J. (1996) Science 274, 1672-1677.
  2. Nevins, J.R. et al. (1992) Science 258, 424-429.
  3. Welch, P.J. and Wang, J.Y. (1993) Cell 75, 779-790.
  4. Hu, Q.J. et al. (1990) EMBO J. 9, 1147-1155.
  5. Knudsen, E.S. and Wang, J.Y. (1997) Mol. Cell. Biol. 17, 5771-5783.
  6. Lundberg, A.S. and Weinberg, R.A. (1998) Mol. Cell. Biol. 18, 753-761.
  7. Connell-Crowley, L. et al. (1997) Mol. Cell. Biol. 8, 287-301.
  8. Kitagawa, M. et al. (1996) EMBO J. 15, 7060-7069.
  9. Geng, Y. et al. (2001) Proc. Natl. Acad. Sci. USA 98, 194-199.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Western Blots: CST recommends using 10 µl (50 ng) of phosphorylated and nonphosphorylated control extracts as controls.

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes